Inventor · disambiguated record
Thazha P. Prakash
Also filed as: PRAKASH THAZHA P · PRAKASH THAZHA R
88 granted patents·97 pending applications·5,507 citations·filing 1998–2024
99Inventor score
Files withIONIS PHARMACEUTICALS INC82ISIS PHARMACEUTICALS INC39BHAT BALKRISHEN22PRAKASH THAZHA P7SWAYZE ERIC E7
Top patents by PatentIndex Score
185 records- 0199US9181549B2Conjugated antisense compounds and their useISIS PHARMACEUTICALS INC·Filed 2014·Granted Nov 10, 2015·69 cites·30 claims
- 0299US9127276B2Conjugated antisense compounds and their useISIS PHARMACEUTICALS INC·Filed 2014·Granted Sep 8, 2015·136 cites·6 claims
- 0399US9005906B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 14, 2015·163 cites·24 claims
- 0499US8440803B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2011·Granted May 14, 2013·158 cites·16 claims
- 0599US7696345B2Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2003·Granted Apr 13, 2010·426 cites·24 claims
- 0698US11299736B1Conjugated antisense compounds and their useIONIS PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·3 cites·21 claims
- 0798US9181550B2Compositions and methods for modulating apolipoprotein (a) expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Nov 10, 2015·16 cites·26 claims
- 0898US9163239B2Compositions and methods for modulating apolipoprotein C-III expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Oct 20, 2015·20 cites·26 claims
- 0998US9145558B2Compositions and methods for modulating HBV expressionISIS PHARMACEUTICALS INC·Filed 2015·Granted Sep 29, 2015·13 cites·24 claims
- 1098US8993738B2Modified nucleosides, analogs thereof and oligomeric compounds prepared therefromPRAKASH THAZHA P·Filed 2011·Granted Mar 31, 2015·53 cites·19 claims
- 1198US8796437B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·85 cites·23 claims
- 1298US8124745B2Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulationALLERSON CHARLES·Filed 2010·Granted Feb 28, 2012·203 cites·20 claims
- 1398US8088904B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2008·Granted Jan 3, 2012·164 cites·30 claims
- 1498US7939677B2Oligomeric compounds comprising 4′-thionucleosides for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2010·Granted May 10, 2011·152 cites·20 claims
- 1598US7875733B2Oligomeric compounds comprising 4′-thionucleosides for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2004·Granted Jan 25, 2011·159 cites·6 claims
- 1698US7569686B1Compounds and methods for synthesis of bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2007·Granted Aug 4, 2009·501 cites·26 claims
- 1798US7125855B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseMERCK & CO INC·Filed 2003·Granted Oct 24, 2006·301 cites·4 claims
- 1898US7105499B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseISIS PHARMACEUTICALS INC·Filed 2002·Granted Sep 12, 2006·233 cites·2 claims
- 1998US6777395B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virusMERCK & CO INC·Filed 2002·Granted Aug 17, 2004·356 cites·13 claims
- 2098US6639062B2Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefromISIS PHARMACEUTICALS INC·Filed 1999·Granted Oct 28, 2003·259 cites·83 claims
- 2198US6534639B1Guanidinium functionalized oligonucleotides and method/synthesisISIS PHARMACEUTICALS INC·Filed 2000·Granted Mar 18, 2003·261 cites·26 claims
- 2297US11851655B2Compositions and methods for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Dec 26, 2023·3 cites·33 claims
- 2397US10844379B2Conjugated antisense compounds and their useIONIS PHARMACEUTICALS INC·Filed 2018·Granted Nov 24, 2020·8 cites·20 claims
- 2497US9957504B2Compositions and methods for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted May 1, 2018·8 cites·56 claims
- 2597US9321799B2Modified nucleosides, analogs thereof and oligomeric compounds prepared therefromIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 26, 2016·17 cites·24 claims
- 2696US10883104B2Compositions and methods for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2018·Granted Jan 5, 2021·5 cites·6 claims
- 2796US10683499B2Compositions and methods for modulating TTR expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Jun 16, 2020·5 cites·53 claims
- 2896US9932580B2Compositions and methods for modulating HBV expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 3, 2018·5 cites·42 claims
- 2996US9932581B2Compositions and methods for modulating apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 3, 2018·6 cites·50 claims
- 3096US8883752B25′ and 2′ BIS-substituted nucleosides and oligomeric compounds prepared therefromSWAYZE ERIC E·Filed 2009·Granted Nov 11, 2014·24 cites·23 claims
- 3196US6172209B1Aminooxy-modified oligonucleotides and methods for making sameISIS PHARMACEUTICALS INC·Filed 1998·Granted Jan 9, 2001·378 cites·37 claims
- 3296US6147200A2'-O-acetamido modified monomers and oligomersISIS PHARMACEUTICALS INC·Filed 1999·Granted Nov 14, 2000·466 cites·46 claims
- 3396US2025346899A1Conjugated antisense compounds and their useIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3495US11084844B2Modified nucleosides, analogs thereof and oligomeric compounds prepared therefromIONIS PHARMACEUTICALS INC·Filed 2018·Granted Aug 10, 2021·8 cites·20 claims
- 3595US9714421B2Compositions and methodsIONIS PHARMACEUTICALS INC·Filed 2014·Granted Jul 25, 2017·5 cites·17 claims
- 3695US8846637B2Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefromSETH PUNIT P·Filed 2011·Granted Sep 30, 2014·21 cites·36 claims
- 3795US8278425B2N-substituted-aminomethylene bridged bicyclic nucleic acid analogsPRAKASH THAZHA P·Filed 2008·Granted Oct 2, 2012·333 cites·30 claims
- 3894US12509684B2Compositions and methods for modulating apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2024·Granted Dec 30, 2025·0 cites·20 claims
- 3994US10570169B2Conjugated antisense compounds and their useIONIS PHARMACEUTICALS INC·Filed 2015·Granted Feb 25, 2020·11 cites·18 claims
- 4094US9957292B2Compositions and methods for modulating angiopoietin-like 3 expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted May 1, 2018·11 cites·81 claims
- 4194US9943604B2Targeted therapeutic nucleosides and their useIONIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 17, 2018·9 cites·16 claims
- 4294US9738895B2Oligomeric compounds and methodsIONIS PHARMACEUTICALS INC·Filed 2015·Granted Aug 22, 2017·10 cites·21 claims
- 4394US9382540B2Compositions and methods for modulating angiopoietin-like 3 expressionISIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 5, 2016·13 cites·28 claims
- 4494US9156873B2Modified 5′ diphosphate nucleosides and oligomeric compounds prepared therefromPRAKASH THAZHA P·Filed 2011·Granted Oct 13, 2015·19 cites·20 claims
- 4594US8987435B2Oligomeric compounds and methodsSWAYZE ERIC E·Filed 2009·Granted Mar 24, 2015·20 cites·23 claims
- 4693US12291709B2Compositions and methods for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2023·Granted May 6, 2025·0 cites·16 claims
- 4793US9994855B2Compositions and methods for modulating growth hormone receptor expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Jun 12, 2018·9 cites·43 claims
- 4893US9127033B25′ modified nucleosides and oligomeric compounds prepared therefromPRAKASH THAZHA P·Filed 2011·Granted Sep 8, 2015·26 cites·20 claims
- 4992US10927372B2Compositions and methods for modulating apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2018·Granted Feb 23, 2021·2 cites·34 claims
- 5092US10280423B2Compositions and methods for modulating complement factor B expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted May 7, 2019·10 cites·36 claims
Showing the top 50 of 185 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thazha P. Prakash files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →